296 related articles for article (PubMed ID: 19798032)
1. Dendritic cells as targets for therapy in rheumatoid arthritis.
Khan S; Greenberg JD; Bhardwaj N
Nat Rev Rheumatol; 2009 Oct; 5(10):566-71. PubMed ID: 19798032
[TBL] [Abstract][Full Text] [Related]
2. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
5. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
6. Targeting DCs for Tolerance Induction: Don't Lose Sight of the Neutrophils.
Hafkamp FMJ; Groot Kormelink T; de Jong EC
Front Immunol; 2021; 12():732992. PubMed ID: 34675923
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells, T cells and their interaction in rheumatoid arthritis.
Wehr P; Purvis H; Law SC; Thomas R
Clin Exp Immunol; 2019 Apr; 196(1):12-27. PubMed ID: 30589082
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
[TBL] [Abstract][Full Text] [Related]
9. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
van Kooten C; Stax AS; Woltman AM; Gelderman KA
Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
[TBL] [Abstract][Full Text] [Related]
10. The type I IFN system in rheumatoid arthritis.
Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
[TBL] [Abstract][Full Text] [Related]
11. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
Passeri L; Marta F; Bassi V; Gregori S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and the induction of tolerance by dendritic cells.
Buckland M; Lombardi G
Handb Exp Pharmacol; 2009; (188):197-213. PubMed ID: 19031027
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells for autoimmune disease and transplantation.
Thomson AW; Robbins PD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
17. PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.
Galea R; Nel HJ; Talekar M; Liu X; Ooi JD; Huynh M; Hadjigol S; Robson KJ; Ting YT; Cole S; Cochlin K; Hitchcock S; Zeng B; Yekollu S; Boks M; Goh N; Roberts H; Rossjohn J; Reid HH; Boyd BJ; Malaviya R; Shealy DJ; Baker DG; Madakamutil L; Kitching AR; O'Sullivan BJ; Thomas R
JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31487265
[TBL] [Abstract][Full Text] [Related]
18. New DiaP277 analogue shifts DCs to tolerogenic, and modulates NF-Kβ1 to suppress autoreactive T lymphocytes in the type 1 diabetic mice.
Alahdal M; Liangliang J; Shiping L; Yun X; Gao H; Jialei Z; Hassan W; Jin L; Rongyue C
Autoimmunity; 2018 Aug; 51(5):210-220. PubMed ID: 30382756
[TBL] [Abstract][Full Text] [Related]
19. STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis.
Prado C; Ugalde V; González H; Figueroa A; López E; Lladser A; Pacheco R
J Immunol Res; 2019; 2019():1982570. PubMed ID: 31355296
[TBL] [Abstract][Full Text] [Related]
20. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
